Journal of King Saud University - Computer and Information Sciences,
Journal Year:
2023,
Volume and Issue:
35(5), P. 101560 - 101560
Published: April 20, 2023
The
existing
methods
for
accurate
brain
tumor
(BT)
segmentation
based
on
homogeneous
datasets
show
significant
performance
degradation
in
actual
clinical
applications
and
lacked
heterogeneous
data
analysis.
To
address
these
issues,
we
designed
a
deep
learning-based
multiscale
dilated
features
up-sampling
network
(MDFU-Net)
BT
from
data.
Our
method
primarily
uses
the
strength
of
(MDF)
inside
encoder
module
to
improve
performance.
For
final
segmentation,
simple
yet
effective
decoder
is
process
dense
spatial
MDF.
experiments,
our
MDFU-Net
trained
one
dataset
tested
with
another
environment,
showing
quantitative
results
Dice
similarity
coefficient
(DC)
62.66%,
intersection
over
union
(IoU)
56.96%,
specificity
(Spe)
99.29%,
sensitivity
(Sen)
51.98%,
which
were
higher
than
those
state-of-the-art
methods.
There
are
several
reasons
lower
values
evaluation
metrics
dataset,
including
change
characteristics
different
MRI
modalities,
presence
minor
lesions,
highly
imbalanced
dataset.
Moreover,
experimental
showed
that
achieved
DC
82.96%,
IoU
74.94%,
Spe
99.89%,
Sen
68.05%,
also
system,
as
well
data,
can
be
advantageous
radiologists
medical
experts.
Journal of Hematology & Oncology,
Journal Year:
2023,
Volume and Issue:
16(1)
Published: Nov. 27, 2023
Research
into
the
potential
benefits
of
artificial
intelligence
for
comprehending
intricate
biology
cancer
has
grown
as
a
result
widespread
use
deep
learning
and
machine
in
healthcare
sector
availability
highly
specialized
datasets.
Here,
we
review
new
approaches
how
they
are
being
used
oncology.
We
describe
might
be
detection,
prognosis,
administration
treatments
introduce
latest
large
language
models
such
ChatGPT
oncology
clinics.
highlight
applications
omics
data
types,
offer
perspectives
on
various
types
combined
to
create
decision-support
tools.
also
evaluate
present
constraints
challenges
applying
precision
Finally,
discuss
current
may
surmounted
make
useful
clinical
settings
future.
Biomedicines,
Journal Year:
2023,
Volume and Issue:
11(2), P. 364 - 364
Published: Jan. 26, 2023
MRI
is
undoubtedly
the
cornerstone
of
brain
tumor
imaging,
playing
a
key
role
in
all
phases
patient
management,
starting
from
diagnosis,
through
therapy
planning,
to
treatment
response
and/or
recurrence
assessment.
Currently,
neuroimaging
can
describe
morphologic
and
non-morphologic
(functional,
hemodynamic,
metabolic,
cellular,
microstructural,
sometimes
even
genetic)
characteristics
tumors,
greatly
contributing
diagnosis
follow-up.
Knowing
technical
aspects,
strength
limits
each
MR
technique
crucial
correctly
interpret
studies
address
clinicians
best
strategy.
This
article
aimed
provide
an
overview
assessment
adult
primary
tumors.
We
started
basilar
conventional/morphological
sequences,
then
analyzed,
one
by
one,
non-morphological
techniques,
finally
highlighted
future
perspectives,
such
as
radiomics
artificial
intelligence.
Journal of Magnetic Resonance Imaging,
Journal Year:
2023,
Volume and Issue:
57(6), P. 1676 - 1695
Published: March 13, 2023
Preoperative
clinical
MRI
protocols
for
gliomas,
brain
tumors
with
dismal
outcomes
due
to
their
infiltrative
properties,
still
rely
on
conventional
structural
MRI,
which
does
not
deliver
information
tumor
genotype
and
is
limited
in
the
delineation
of
diffuse
gliomas.
The
GliMR
COST
action
wants
raise
awareness
about
state
art
advanced
techniques
gliomas
possible
translation.
This
review
describes
current
methods,
limits,
applications
preoperative
assessment
glioma,
summarizing
level
validation
different
techniques.
In
this
second
part,
we
magnetic
resonance
spectroscopy
(MRS),
chemical
exchange
saturation
transfer
(CEST),
susceptibility-weighted
imaging
(SWI),
MRI-PET,
MR
elastography
(MRE),
MR-based
radiomics
applications.
first
part
addresses
dynamic
susceptibility
contrast
(DSC)
contrast-enhanced
(DCE)
arterial
spin
labeling
(ASL),
diffusion-weighted
vessel
imaging,
fingerprinting
(MRF).
EVIDENCE
LEVEL:
3.
TECHNICAL
EFFICACY:
Stage
2.
Cancers,
Journal Year:
2024,
Volume and Issue:
16(3), P. 576 - 576
Published: Jan. 30, 2024
This
study
delineates
the
pivotal
role
of
imaging
within
field
neurology,
emphasizing
its
significance
in
diagnosis,
prognostication,
and
evaluation
treatment
responses
for
central
nervous
system
(CNS)
tumors.
A
comprehensive
understanding
both
capabilities
limitations
inherent
emerging
technologies
is
imperative
delivering
a
heightened
level
personalized
care
to
individuals
with
neuro-oncological
conditions.
Ongoing
research
endeavors
rectify
some
radiological
modalities,
aiming
augment
accuracy
efficacy
management
brain
review
dedicated
comparison
critical
examination
latest
advancements
diverse
modalities
employed
neuro-oncology.
The
objective
investigate
their
respective
impacts
on
cancer
staging,
prognosis,
post-treatment
monitoring.
By
providing
analysis
these
this
aims
contribute
collective
knowledge
field,
fostering
an
informed
approach
care.
In
conclusion,
outlook
appears
promising,
sustained
exploration
domain
anticipated
yield
further
breakthroughs,
ultimately
enhancing
outcomes
grappling
CNS
Liver International,
Journal Year:
2024,
Volume and Issue:
44(6), P. 1351 - 1362
Published: March 4, 2024
Accurate
preoperative
prediction
of
microvascular
invasion
(MVI)
and
recurrence-free
survival
(RFS)
is
vital
for
personalised
hepatocellular
carcinoma
(HCC)
management.
We
developed
a
multitask
deep
learning
model
to
predict
MVI
RFS
using
MRI
scans.
IEEE Access,
Journal Year:
2024,
Volume and Issue:
12, P. 72105 - 72116
Published: Jan. 1, 2024
Accurate
segmentation
of
brain
tumors
from
MRI
sequences
is
essential
across
diverse
clinical
scenarios,
facilitating
precise
delineation
anatomical
structures
and
disease-affected
areas.
This
study
presents
an
innovative
deep-learning
method
for
segmenting
glioma
tumors,
utilizing
a
hybrid
architecture
that
combines
ResNet
U-Net
with
Transformer
blocks.
The
proposed
model
adeptly
encompasses
both
the
local
global
contextual
details
present
in
scans.
includes
encoder
based
on
extracting
hierarchical
features,
followed
by
residual
blocks
to
enhance
feature
representation
while
maintaining
spatial
information.
Additionally,
central
transformer
block,
incorporating
Multi-Head
Attention
mechanisms,
enables
modeling
long-range
dependencies
comprehension,
progressively
refining
interactions.
To
handle
structural
scale
variations
within
images,
skip
connections
are
utilized
during
decoding
phase.
Transposed
convolutional
layers
decoder
upsample
maps,
retaining
information
earlier
layers.
A
rigorous
assessment
model's
functionality
was
carried
out
BraTS2019
dataset,
employing
comprehensive
set
evaluation
metrics
including
accuracy,
IOU
score,
specificity,
sensitivity,
dice
precision.
focused
individual
tumor
classes,
namely
whole,
core,
enhancing
regions.
During
validation,
suggested
demonstrated
remarkable
scores
0.91,
0.89,
0.84
whole
tumor,
core
respectively,
yielding
impressive
overall
accuracy
rate
98%.
Critical Reviews in Oncology/Hematology,
Journal Year:
2025,
Volume and Issue:
unknown, P. 104682 - 104682
Published: March 1, 2025
Brain
tumors
refer
to
the
abnormal
growths
that
occur
within
brain's
tissue,
comprising
both
primary
neoplasms
and
metastatic
lesions.
Timely
detection,
precise
staging,
suitable
treatment,
standardized
management
are
of
significant
clinical
importance
for
extending
survival
rates
brain
tumor
patients.
Artificial
intelligence
(AI),
a
discipline
computer
science,
is
leveraging
its
robust
capacity
information
identification
combination
revolutionize
traditional
paradigms
oncology
care,
offering
substantial
potential
precision
medicine.
This
article
provides
an
overview
current
applications
AI
in
tumors,
encompassing
technologies,
their
working
mechanisms
workflow,
contributions
diagnosis
as
well
role
scientific
research,
particularly
drug
innovation
revealing
microenvironment.
Finally,
paper
addresses
existing
challenges,
solutions,
future
application
prospects.
review
aims
enhance
our
understanding
provide
valuable
insights
forthcoming
inquiries.
Frontiers in Bioscience-Landmark,
Journal Year:
2025,
Volume and Issue:
30(3)
Published: March 19, 2025
Background:
The
study
sought
to
establish
a
radiogenomic
signature
evaluate
the
transcriptional
heterogeneity
that
reflects
prognosis
and
tumour-related
biological
functions
of
patients
with
glioblastoma.
Methods:
Transcriptional
subclones
were
identified
via
fully
unsupervised
deconvolution
RNA
sequencing.
A
genomic
prognostic
risk
score
was
developed
from
subclone
proportions
in
development
dataset
(n
=
532)
independently
verified
testing
225).
Multimodal
magnetic
resonance
imaging
(MRI)
analysis
involved
feature
extraction
three
distinct
anatomical
regions
across
four
sequences.
Key
features
selected
construct
predictive
99),
subsequent
survival
conducted
image
233).
Results:
total
8
identified,
which
metabolic
pathway
spinocerebellar
ataxia
independent
factors
for
overall
survival.
effectively
differentiated
patient
subgroups
divergent
outcomes
both
(p
<
0.001)
datasets
0.0003).
Nineteen
radiomic
signature,
these
being
linked
hallmark
cancer
pathways
malignant
behaviours
cells.
predicted
(hazard
ratios
(HR)
1.67,
p
0.011).
Conclusions:
established
characterize
underlying
Neuro-Oncology Advances,
Journal Year:
2023,
Volume and Issue:
5(1)
Published: Jan. 1, 2023
Abstract
Background
IDH
mutation
and
1p/19q
codeletion
status
are
important
prognostic
markers
for
glioma
that
currently
determined
using
invasive
procedures.
Our
goal
was
to
develop
artificial
intelligence-based
methods
noninvasively
determine
molecular
alterations
from
MRI.
Methods
Pre-operative
MRI
scans
of
2648
patients
were
collected
Washington
University
School
Medicine
(WUSM;
n
=
835)
publicly
available
Brain
Tumor
Segmentation
(BraTS;
378),
LGG
(n
159),
Ivy
Glioblastoma
Atlas
Project
(Ivy
GAP;
41),
The
Cancer
Genome
(TCGA;
461),
the
Erasmus
Glioma
Database
(EGD;
774)
datasets.
A
2.5D
hybrid
convolutional
neural
network
proposed
simultaneously
localize
classify
its
by
leveraging
imaging
features
prior
knowledge
clinical
records
tumor
location.
models
trained
on
223
348
cases
tasks,
respectively,
tested
one
internal
(TCGA)
two
external
(WUSM
EGD)
test
sets.
Results
For
IDH,
best-performing
model
achieved
areas
under
receiver
operating
characteristic
(AUROC)
0.925,
0.874,
0.933
precision-recall
curves
(AUPRC)
0.899,
0.702,
0.853
internal,
WUSM,
EGD
sets,
respectively.
1p/19q,
best
AUROCs
0.782,
0.754,
0.842,
AUPRCs
0.588,
0.713,
those
three
data-splits,
Conclusions
high
accuracy
unseen
data
showcases
generalization
capabilities
suggests
potential
perform
“virtual
biopsy”
tailoring
treatment
planning
overall
management
gliomas.